This inventor holds 3 USPTO granted patents. Top assignees: British Technology Group Limited, Btg International Limited. Active years: 1993-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- West Croyden, GB (1993)
- West Croydon, GB (1996 - 1999)
Company Filing History:
Years Active: 1993-1999
Title: Surinder Singh: Innovator in Medicinal Chemistry
Introduction
Surinder Singh is a notable inventor based in West Croydon, GB. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative patents. With a total of 3 patents, Singh has focused on developing compounds that have potential therapeutic applications.
Latest Patents
One of Surinder Singh's latest patents is titled "Use of xanthine oxidase inhibitors as anti-ischaemic agents." This patent describes a compound of formula I, which includes various chemical groupings that can form hydroxamate moieties. These compounds are designed for the manufacture of a medicament intended for use as an anti-ischaemic agent. Another significant patent involves "3-hydroxypyridin-4-one derivatives as chelating agents," which further showcases his expertise in creating innovative chemical solutions.
Career Highlights
Throughout his career, Surinder Singh has worked with reputable organizations, including British Technology Group Limited and BTG International Limited. His work in these companies has allowed him to advance his research and contribute to the development of new medicinal products.
Collaborations
Surinder Singh has collaborated with esteemed colleagues, including Robert Charles Hider and Timothy E Peto. These partnerships have enriched his research and expanded the impact of his inventions in the field.
Conclusion
Surinder Singh's contributions to medicinal chemistry through his patents highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to influence the development of new therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

